Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shridar Ganesan

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
JCO Precision Oncology|February 9, 2022
Tumor Suppressor Tolerance: Reversion Mutations in BRCA1 and BRCA2 and Resistance to PARP Inhibitors and PlatinumShridar Ganesan
JCO Precision Oncology|December 14, 2023
Treating Early and Often: Targeted Therapeutics in the Adjuvant SettingShridar Ganesan
The Journal of Clinical Investigation|August 15, 2022
Breaking satellite silence: human satellite II RNA expression in ovarian cancerShridar Ganesan
Science Signaling|March 31, 2011
MYC, PARP1, and chemoresistance: BIN there, done that?Shridar Ganesan
Journal of Molecular Cell Biology|February 1, 2011
BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viabilityAmal Aly, Shridar Ganesan
JCO Precision Oncology|January 20, 2022
Poly (ADP-Ribose) Polymerase Inhibitor Activity in Prostate Cancers Harboring Mutations in DNA Repair Genes: Who Benefits?Shridar Ganesan, Judy Garber
Frontiers in Genetics|August 9, 2021
Genomic and Immunologic Correlates of Indoleamine 2,3-Dioxygenase Pathway Expression in CancerAnshuman Panda, Shridar Ganesan
Current Opinion in Obstetrics & Gynecology|December 19, 2013
Triple-negative breast cancer: molecular subtypes and targeted therapyKim M Hirshfield, Shridar Ganesan
Cancer|November 12, 2025
Microsatellite instability: Advances in diagnosisPatrick M Boland, Shridar Ganesan
Nature Cancer|April 26, 2021
Emerging strategies for treating metastasisMark Esposito, Shridar Ganesan, Yibin Kang
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
JCO Precision Oncology|February 9, 2022
Tumor Suppressor Tolerance: Reversion Mutations in BRCA1 and BRCA2 and Resistance to PARP Inhibitors and PlatinumShridar Ganesan
JCO Precision Oncology|December 14, 2023
Treating Early and Often: Targeted Therapeutics in the Adjuvant SettingShridar Ganesan
The Journal of Clinical Investigation|August 15, 2022
Breaking satellite silence: human satellite II RNA expression in ovarian cancerShridar Ganesan
Science Signaling|March 31, 2011
MYC, PARP1, and chemoresistance: BIN there, done that?Shridar Ganesan
Journal of Molecular Cell Biology|February 1, 2011
BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viabilityAmal Aly, Shridar Ganesan
JCO Precision Oncology|January 20, 2022
Poly (ADP-Ribose) Polymerase Inhibitor Activity in Prostate Cancers Harboring Mutations in DNA Repair Genes: Who Benefits?Shridar Ganesan, Judy Garber
Frontiers in Genetics|August 9, 2021
Genomic and Immunologic Correlates of Indoleamine 2,3-Dioxygenase Pathway Expression in CancerAnshuman Panda, Shridar Ganesan
Current Opinion in Obstetrics & Gynecology|December 19, 2013
Triple-negative breast cancer: molecular subtypes and targeted therapyKim M Hirshfield, Shridar Ganesan
Cancer|November 12, 2025
Microsatellite instability: Advances in diagnosisPatrick M Boland, Shridar Ganesan
Nature Cancer|April 26, 2021
Emerging strategies for treating metastasisMark Esposito, Shridar Ganesan, Yibin Kang
Pageof 18